Trial results for the KanSurvive study, which investigated improving cancer survivorship care in rural practices for conditions including Breast Cancer, were posted on ClinicalTrials.gov on 2026-01-14, with an enrollment of 15 participants.
Background
Cancer survivorship care is a critical phase following active treatment, focusing on long-term health, quality of life, and surveillance for recurrence. In rural areas, access to specialized care and consistent follow-up can be challenging, leading to potential gaps in care delivery. Interventions aimed at improving the adoption of high-quality survivorship care in these settings are important to ensure patients receive comprehensive support after their initial treatment. The KanSurvive study aimed to address these challenges by testing a model for improving care in rural primary care practices.
Trial design
This completed study, designated as Phase NA, enrolled 15 participants across approximately 20 rural primary care practices. The trial investigated improving survivorship care for patients with Breast Cancer, Colorectal Cancer, Lung Cancer, and Prostate Cancer. It was designed as a delayed intervention-controlled trial, testing the effectiveness of the novel KanSurvive-ECHO intervention combined with practice facilitation.
Key results
The trial reported several key measurements related to cancer survivorship performance indicators before and after the KanSurvive ECHO + Practice Facilitation intervention:
- Tumor Surveillance Completion: Pre-intervention 126 participants; Post-intervention 117 participants.
- Distress Screening Completion: Pre-intervention 116 participants; Post-intervention 116 participants.
- Body Mass Index (BMI) Assessment Completion: Pre-intervention 132 participants; Post-intervention 118 participants.
- Tobacco Use Screening Completion: Pre-intervention 115 participants; Post-intervention 119 participants.
- Cancer Diagnosis on Problem List: Pre-intervention 129 participants; Post-intervention 122 participants.
- Family History of Cancer Documentation: Pre-intervention 96 participants; Post-intervention 115 participants.
Statistical analyses were performed to assess differences in cancer survivorship performance indicators and surveillance rates. These included Chi-squared and Fisher Exact tests, with a p-value of 0.05 reported for these analyses.
What this means
The posted results from the KanSurvive study indicate varied impacts of the KanSurvive-ECHO intervention on cancer survivorship care performance indicators in rural practices. While some metrics, such as tobacco use screening completion and family history of cancer documentation, showed an increase post-intervention, others like tumor surveillance completion, BMI assessment completion, and cancer diagnosis on problem list documentation saw a decrease. Distress screening completion remained unchanged. These mixed outcomes suggest that implementing models for improving survivorship care in rural settings may have complex and differential effects across various care processes, highlighting the need for further refinement and targeted strategies.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04763824, titled "KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice", were posted on 2026-01-14 on clinicaltrials.gov.